Header (Kopie) (Kopie)

IQ Innovation Award for Antituberculosis Agent BTZ043

The innovation of the year 2019 in Central Germany is the new Antituberculosis Agent BTZ043. It isbeing developed into a drug by scientists of the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI) in Jena and their partners at the University Hospital Munich as well as HAPILA Ltd. Gera.

Link zur Pressemitteilung (Deutsch)

Photo: GWP I Guido Werner

Back